» Articles » PMID: 2502200

Production of Colony-stimulating Activity by Human Natural Killer Cells: Analysis of the Conditions That Influence the Release and Detection of Colony-stimulating Activity

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1989 Jul 1
PMID 2502200
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Highly purified natural killer (NK) cell suspensions were tested for their capacity to release colony-stimulating activity (CSA) in vitro. NK cell suspensions comprised primarily CD16+ cells and were devoid of CD3+ T cells, CD15+ monocytes, and of B cells. CSA was detected in the NK cell supernatants and sustained the growth of myeloid colonies from both normal peripheral blood and bone marrow. CSA could be in part inhibited by pretreating NK cell culture supernatants with a specific goat anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antiserum. The inhibition, however, was never complete, a finding that suggests that additional factors were responsible for CSA. Incubation of NK cells with K562 cells (an NK-sensitive target) or with normal bone marrow cells resulted in the appearance of a strong colony-inhibiting activity (CIA) in the culture supernatants. Such CIA was demonstrable in an experimental system where bone marrow or peripheral blood progenitors were induced to form myeloid colonies in the presence of conditioned medium by CSA-producing giant cell tumor (GCT) cells. Stimulation of NK cells with NK-insensitive targets failed to induce CIA production. Neutralizing antitumor necrosis factor (TNF) monoclonal antibodies (MoAbs) were found capable of inhibiting CIA present in the supernatants of NK cells stimulated with K562 cells. Following treatment with anti-TNF antibodies, CSA was again detectable in the same supernatants. This finding indicates that induction of TNF production did not concomitantly switch off CSA production by NK cells. Pretreatment of NK cells with recombinant interleukin-2 (rIL-2) or gamma interferon (r gamma IFN) did not change the amount of CSA released. However, treatment with rIL-2 caused the appearance of a factor in the NK cell supernatants capable of sustaining the formation of colonies of a larger size.

Citing Articles

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N Clin Exp Immunol. 2008; 152(2):219-26.

PMID: 18336590 PMC: 2384094. DOI: 10.1111/j.1365-2249.2008.03624.x.


Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production.

Murphy J, Zhou A, Wong S Infect Immun. 1997; 65(11):4564-71.

PMID: 9353034 PMC: 175655. DOI: 10.1128/iai.65.11.4564-4571.1997.


Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Keutzer J, Sytkowski A Proc Natl Acad Sci U S A. 1995; 92(11):4967-71.

PMID: 7761433 PMC: 41828. DOI: 10.1073/pnas.92.11.4967.


Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Blanchard D, Pearson C, McMILLEN S, Djeu J Infect Immun. 1991; 59(7):2396-402.

PMID: 2050405 PMC: 258024. DOI: 10.1128/iai.59.7.2396-2402.1991.


Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.

Rolstad B, Benestad H Immunology. 1991; 74(1):86-93.

PMID: 1937576 PMC: 1384676.